Home › Immunoglobulin Light-chain Amyloidosis › Utah › Salt Lake City
Immunoglobulin Light-chain Amyloidosis clinical trials in Salt Lake City, UT
3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
RecruitingPhase 2
- GSK Investigational Site, Salt Lake City
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
RecruitingObservational study
- University of Utah, Huntsman Cancer Hospital, Salt Lake City
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RecruitingPhase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Immunoglobulin Light-chain Amyloidosis trials in other cities
- Boston, MA8 studies
- Rochester, MN5 studies
- Durham, NC4 studies
- New York City, NY4 studies
- New Haven, CT3 studies
- Columbus, OH3 studies
- Cleveland, OH3 studies
- Nashville, TN3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer27 studies
- Cancer (all types)25 studies
- Colorectal Cancer22 studies
- Multiple Myeloma22 studies
- Ovarian Cancer19 studies
- Lung Cancer19 studies
- Melanoma19 studies
- Metastatic Cancer17 studies
- Heart Failure17 studies
- Acute Myeloid Leukemia17 studies
- Obesity16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.